C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01)
Patent
CA 2640386
Compounds of formula (I) inhibit microtubule affinity regulating kinase (MARK), and hence are suitable for treating diseases associated with abnormal phosphorylation of tau.
Les composés de formule I : inhibent la kinase régulant l'affinité pour les microtubules (MARK, microtubule affinity regulating kinase) et, de ce fait, sont adéquats pour traiter des maladies associées à une phosphorylation anormale de tau.
Churcher Ian
Hunt Peter Alan
Stanton Matthew G.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Treatment of alzheimer's disease and related conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of alzheimer's disease and related conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of alzheimer's disease and related conditions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1346507